company logo
NextImmune is a privately held biotechnology company.
Basic Information
NextImmune focuses on the research and development of a new generation of immunosuppressive drugs for autoimmune diseases and Organ Transplantation - with objectives of high efficacy and good safety without adverse effects as known from conventional immunosuppressants.
Legal Name
:
NextImmune AG
Headquarters
:
Basel, Basel-Stadt, Switzerland
Founding Date
:
2021
No. of Employees
:
11 to 20
Core Team
:
1.  
Rajesh Jayachandran
Chief Scientific Officer and Co-Founder